Keywords: wyeth, eps, increases, during, 2nd, qtr, posted
Wyeth EPS increases 25% during 2nd qtr
Article | 29 July 2002
Wyeth has posted worldwide net revenue of $3.5 billion forsecond-quarter 2002, an increase of 10% on the like, year-earlier period. Net income was $599.9 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
